Request for Covid-19 Impact Assessment of this Report
The United States Antibody Humanization market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antibody Humanization market, reaching US$ million by the year 2028. As for the Europe Antibody Humanization landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antibody Humanization players cover Accurus Biosciences, IONTAS, Lonza, and Oak BioSciences, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Humanization market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Monoclonal Antibodies
Bispecific Antibodies
CDR Grafted Antibodies
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
HIV
SARS
RSV
Prion
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Accurus Biosciences
IONTAS
Lonza
Oak BioSciences
Panorama Research
PX'Therapeutics
Yurogen Biosystems
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody Humanization Market Size 2017-2028
2.1.2 Antibody Humanization Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Antibody Humanization Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Bispecific Antibodies
2.2.3 CDR Grafted Antibodies
2.3 Antibody Humanization Market Size by Type
2.3.1 Antibody Humanization Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Antibody Humanization Market Size Market Share by Type (2017-2022)
2.4 Antibody Humanization Segment by Application
2.4.1 HIV
2.4.2 SARS
2.4.3 RSV
2.4.4 Prion
2.5 Antibody Humanization Market Size by Application
2.5.1 Antibody Humanization Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Antibody Humanization Market Size Market Share by Application (2017-2022)
3 Antibody Humanization Market Size by Player
3.1 Antibody Humanization Market Size Market Share by Players
3.1.1 Global Antibody Humanization Revenue by Players (2020-2022)
3.1.2 Global Antibody Humanization Revenue Market Share by Players (2020-2022)
3.2 Global Antibody Humanization Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antibody Humanization by Regions
4.1 Antibody Humanization Market Size by Regions (2017-2022)
4.2 Americas Antibody Humanization Market Size Growth (2017-2022)
4.3 APAC Antibody Humanization Market Size Growth (2017-2022)
4.4 Europe Antibody Humanization Market Size Growth (2017-2022)
4.5 Middle East & Africa Antibody Humanization Market Size Growth (2017-2022)
5 Americas
5.1 Americas Antibody Humanization Market Size by Country (2017-2022)
5.2 Americas Antibody Humanization Market Size by Type (2017-2022)
5.3 Americas Antibody Humanization Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Humanization Market Size by Region (2017-2022)
6.2 APAC Antibody Humanization Market Size by Type (2017-2022)
6.3 APAC Antibody Humanization Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibody Humanization by Country (2017-2022)
7.2 Europe Antibody Humanization Market Size by Type (2017-2022)
7.3 Europe Antibody Humanization Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody Humanization by Region (2017-2022)
8.2 Middle East & Africa Antibody Humanization Market Size by Type (2017-2022)
8.3 Middle East & Africa Antibody Humanization Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antibody Humanization Market Forecast
10.1 Global Antibody Humanization Forecast by Regions (2023-2028)
10.1.1 Global Antibody Humanization Forecast by Regions (2023-2028)
10.1.2 Americas Antibody Humanization Forecast
10.1.3 APAC Antibody Humanization Forecast
10.1.4 Europe Antibody Humanization Forecast
10.1.5 Middle East & Africa Antibody Humanization Forecast
10.2 Americas Antibody Humanization Forecast by Country (2023-2028)
10.2.1 United States Antibody Humanization Market Forecast
10.2.2 Canada Antibody Humanization Market Forecast
10.2.3 Mexico Antibody Humanization Market Forecast
10.2.4 Brazil Antibody Humanization Market Forecast
10.3 APAC Antibody Humanization Forecast by Region (2023-2028)
10.3.1 China Antibody Humanization Market Forecast
10.3.2 Japan Antibody Humanization Market Forecast
10.3.3 Korea Antibody Humanization Market Forecast
10.3.4 Southeast Asia Antibody Humanization Market Forecast
10.3.5 India Antibody Humanization Market Forecast
10.3.6 Australia Antibody Humanization Market Forecast
10.4 Europe Antibody Humanization Forecast by Country (2023-2028)
10.4.1 Germany Antibody Humanization Market Forecast
10.4.2 France Antibody Humanization Market Forecast
10.4.3 UK Antibody Humanization Market Forecast
10.4.4 Italy Antibody Humanization Market Forecast
10.4.5 Russia Antibody Humanization Market Forecast
10.5 Middle East & Africa Antibody Humanization Forecast by Region (2023-2028)
10.5.1 Egypt Antibody Humanization Market Forecast
10.5.2 South Africa Antibody Humanization Market Forecast
10.5.3 Israel Antibody Humanization Market Forecast
10.5.4 Turkey Antibody Humanization Market Forecast
10.5.5 GCC Countries Antibody Humanization Market Forecast
10.6 Global Antibody Humanization Forecast by Type (2023-2028)
10.7 Global Antibody Humanization Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Accurus Biosciences
11.1.1 Accurus Biosciences Company Information
11.1.2 Accurus Biosciences Antibody Humanization Product Offered
11.1.3 Accurus Biosciences Antibody Humanization Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Accurus Biosciences Main Business Overview
11.1.5 Accurus Biosciences Latest Developments
11.2 IONTAS
11.2.1 IONTAS Company Information
11.2.2 IONTAS Antibody Humanization Product Offered
11.2.3 IONTAS Antibody Humanization Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 IONTAS Main Business Overview
11.2.5 IONTAS Latest Developments
11.3 Lonza
11.3.1 Lonza Company Information
11.3.2 Lonza Antibody Humanization Product Offered
11.3.3 Lonza Antibody Humanization Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Lonza Main Business Overview
11.3.5 Lonza Latest Developments
11.4 Oak BioSciences
11.4.1 Oak BioSciences Company Information
11.4.2 Oak BioSciences Antibody Humanization Product Offered
11.4.3 Oak BioSciences Antibody Humanization Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Oak BioSciences Main Business Overview
11.4.5 Oak BioSciences Latest Developments
11.5 Panorama Research
11.5.1 Panorama Research Company Information
11.5.2 Panorama Research Antibody Humanization Product Offered
11.5.3 Panorama Research Antibody Humanization Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Panorama Research Main Business Overview
11.5.5 Panorama Research Latest Developments
11.6 PX'Therapeutics
11.6.1 PX'Therapeutics Company Information
11.6.2 PX'Therapeutics Antibody Humanization Product Offered
11.6.3 PX'Therapeutics Antibody Humanization Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 PX'Therapeutics Main Business Overview
11.6.5 PX'Therapeutics Latest Developments
11.7 Yurogen Biosystems
11.7.1 Yurogen Biosystems Company Information
11.7.2 Yurogen Biosystems Antibody Humanization Product Offered
11.7.3 Yurogen Biosystems Antibody Humanization Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Yurogen Biosystems Main Business Overview
11.7.5 Yurogen Biosystems Latest Developments
12 Research Findings and Conclusion
Table 1. Antibody Humanization Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Bispecific Antibodies
Table 4. Major Players of CDR Grafted Antibodies
Table 5. Antibody Humanization Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Antibody Humanization Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Antibody Humanization Market Size Market Share by Type (2017-2022)
Table 8. Antibody Humanization Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Antibody Humanization Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Antibody Humanization Market Size Market Share by Application (2017-2022)
Table 11. Global Antibody Humanization Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Antibody Humanization Revenue Market Share by Player (2020-2022)
Table 13. Antibody Humanization Key Players Head office and Products Offered
Table 14. Antibody Humanization Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Antibody Humanization Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Antibody Humanization Market Size Market Share by Regions (2017-2022)
Table 19. Americas Antibody Humanization Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Antibody Humanization Market Size Market Share by Country (2017-2022)
Table 21. Americas Antibody Humanization Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Antibody Humanization Market Size Market Share by Type (2017-2022)
Table 23. Americas Antibody Humanization Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Antibody Humanization Market Size Market Share by Application (2017-2022)
Table 25. APAC Antibody Humanization Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Antibody Humanization Market Size Market Share by Region (2017-2022)
Table 27. APAC Antibody Humanization Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Antibody Humanization Market Size Market Share by Type (2017-2022)
Table 29. APAC Antibody Humanization Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Antibody Humanization Market Size Market Share by Application (2017-2022)
Table 31. Europe Antibody Humanization Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Antibody Humanization Market Size Market Share by Country (2017-2022)
Table 33. Europe Antibody Humanization Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Antibody Humanization Market Size Market Share by Type (2017-2022)
Table 35. Europe Antibody Humanization Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Antibody Humanization Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Antibody Humanization Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Antibody Humanization Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Antibody Humanization Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Antibody Humanization Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Antibody Humanization Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Antibody Humanization Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Antibody Humanization
Table 44. Key Market Challenges & Risks of Antibody Humanization
Table 45. Key Industry Trends of Antibody Humanization
Table 46. Global Antibody Humanization Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Antibody Humanization Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Antibody Humanization Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Antibody Humanization Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Antibody Humanization Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Antibody Humanization Market Size Market Share Forecast by Application (2023-2028)
Table 52. Accurus Biosciences Details, Company Type, Antibody Humanization Area Served and Its Competitors
Table 53. Accurus Biosciences Antibody Humanization Product Offered
Table 54. Accurus Biosciences Antibody Humanization Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Accurus Biosciences Main Business
Table 56. Accurus Biosciences Latest Developments
Table 57. IONTAS Details, Company Type, Antibody Humanization Area Served and Its Competitors
Table 58. IONTAS Antibody Humanization Product Offered
Table 59. IONTAS Main Business
Table 60. IONTAS Antibody Humanization Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. IONTAS Latest Developments
Table 62. Lonza Details, Company Type, Antibody Humanization Area Served and Its Competitors
Table 63. Lonza Antibody Humanization Product Offered
Table 64. Lonza Main Business
Table 65. Lonza Antibody Humanization Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Lonza Latest Developments
Table 67. Oak BioSciences Details, Company Type, Antibody Humanization Area Served and Its Competitors
Table 68. Oak BioSciences Antibody Humanization Product Offered
Table 69. Oak BioSciences Main Business
Table 70. Oak BioSciences Antibody Humanization Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Oak BioSciences Latest Developments
Table 72. Panorama Research Details, Company Type, Antibody Humanization Area Served and Its Competitors
Table 73. Panorama Research Antibody Humanization Product Offered
Table 74. Panorama Research Main Business
Table 75. Panorama Research Antibody Humanization Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Panorama Research Latest Developments
Table 77. PX'Therapeutics Details, Company Type, Antibody Humanization Area Served and Its Competitors
Table 78. PX'Therapeutics Antibody Humanization Product Offered
Table 79. PX'Therapeutics Main Business
Table 80. PX'Therapeutics Antibody Humanization Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. PX'Therapeutics Latest Developments
Table 82. Yurogen Biosystems Details, Company Type, Antibody Humanization Area Served and Its Competitors
Table 83. Yurogen Biosystems Antibody Humanization Product Offered
Table 84. Yurogen Biosystems Main Business
Table 85. Yurogen Biosystems Antibody Humanization Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Yurogen Biosystems Latest Developments
List of Figures
Figure 1. Antibody Humanization Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antibody Humanization Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Antibody Humanization Market Size Market Share by Type in 2021
Figure 7. Antibody Humanization in HIV
Figure 8. Global Antibody Humanization Market: HIV (2017-2022) & ($ Millions)
Figure 9. Antibody Humanization in SARS
Figure 10. Global Antibody Humanization Market: SARS (2017-2022) & ($ Millions)
Figure 11. Antibody Humanization in RSV
Figure 12. Global Antibody Humanization Market: RSV (2017-2022) & ($ Millions)
Figure 13. Antibody Humanization in Prion
Figure 14. Global Antibody Humanization Market: Prion (2017-2022) & ($ Millions)
Figure 15. Global Antibody Humanization Market Size Market Share by Application in 2021
Figure 16. Global Antibody Humanization Revenue Market Share by Player in 2021
Figure 17. Global Antibody Humanization Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Antibody Humanization Market Size 2017-2022 ($ Millions)
Figure 19. APAC Antibody Humanization Market Size 2017-2022 ($ Millions)
Figure 20. Europe Antibody Humanization Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Antibody Humanization Market Size 2017-2022 ($ Millions)
Figure 22. Americas Antibody Humanization Value Market Share by Country in 2021
Figure 23. Americas Antibody Humanization Consumption Market Share by Type in 2021
Figure 24. Americas Antibody Humanization Market Size Market Share by Application in 2021
Figure 25. United States Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Antibody Humanization Market Size Market Share by Region in 2021
Figure 30. APAC Antibody Humanization Market Size Market Share by Application in 2021
Figure 31. China Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Antibody Humanization Market Size Market Share by Country in 2021
Figure 38. Europe Antibody Humanization Market Size Market Share by Type in 2021
Figure 39. Europe Antibody Humanization Market Size Market Share by Application in 2021
Figure 40. Germany Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Antibody Humanization Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Antibody Humanization Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Antibody Humanization Market Size Market Share by Application in 2021
Figure 48. Egypt Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Antibody Humanization Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 54. APAC Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 55. Europe Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 57. United States Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 58. Canada Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 61. China Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 62. Japan Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 63. Korea Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 65. India Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 66. Australia Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 67. Germany Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 68. France Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 69. UK Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 70. Italy Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 71. Russia Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 72. Spain Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 75. Israel Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Antibody Humanization Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Antibody Humanization Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...